The U.S. Food and Drug Administration has approved two new oral antibiotics for the treatment of uncomplicated urogenital gonorrhea, marking the first new classes of medications for the sexually transmitted infection in decades. Gepotidacin (Blujepa) and zoliflodacin (Nuzolvence) offer new treatment options as gonorrhea continues to develop resistance to existing Read more…
A San Francisco sexual health clinic significantly reduced rates of bacterial sexually transmitted infections (STIs) among patients by preemptively prescribing the antibiotic doxycycline for use after unprotected sex (DoxyPEP). The study, which appeared in the August edition of the journal Sexually Transmitted Infections, focused on patients who take pre-exposure prophylaxis Read more…
UK health authorities are urging Gay and Bisexual men to get tested after a significant rise in drug-resistant Shigella cases. New data published by the UK Health Security Agency on 26 March shows 2,560 diagnoses of sexually transmitted Shigella in England in 2025 — up from 2,052 in 2023 and Read more…
We are proud that Golden Rule Services (GRS) has been a beneficiary of NCAC’s generosity for 14 years, receiving funding that directly supports rapid HIV, HCV, and STD testing, condom distribution, and PrEP/PEP navigation for high-risk populations. This support also fuels HIV navigation services for newly diagnosed individuals, strengthening GRS’s Read more…
This World AIDS Day, we honor 38 years of remembrance, action, and hope. Golden Rule Services has led HIV prevention and education in Sacramento for nearly 26 years, offering FREE, confidential HIV testing and community-centered care. Now more than ever, your support helps protect progress. #WorldAIDSDay #KnowYourStatus #StopHIVTogether #Sacramento #HIVAwareness Read more…
The Golden Rule Services (GRS) honored founder and executive director Clarmundo Sullivan with a formal resolution presented by Maggy Krell of the California State Assembly. The document, adopted Oct. 1, recognizes Sullivan’s more than 25 years of service providing HIV, STI and hepatitis‐C education, testing and care to underserved Black, Read more…
Researchers say a new laboratory approach may offer a step toward finally eliminating hidden HIV in the body, rather than only suppressing it with medication. Scientists at the Houston Methodist Research Institute reported that they have found a way to expose and destroy dormant HIV hiding inside immune cells — Read more…
Scientists are making progress toward a future HIV vaccine by showing that multiple vaccine components can work together to trigger a strong immune response. A team from several leading research institutes tested a strategy that uses several “germline-targeting” vaccine pieces at the same time. These special vaccine components are designed Read more…
A promising new HIV treatment called pirmitegravir has shown encouraging early results in human clinical trials. Researchers presented the findings at the IDWeek 2025 medical conference. Pirmitegravir belongs to a brand-new class of HIV medicines called allosteric integrase inhibitors. Unlike current HIV drugs that target the virus in familiar ways, Read more…
Health officials have identified three cases of Clade I mpox in Southern California residents with no history of international travel, confirming local community spread. Clade I differs from the more common Clade II strain and can cause more severe illness, though the overall public risk remains low. Those at higher Read more…